Company
Opko Health
Last checked: Nov 20, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations
FDA decisions since 2015
1
510(k), De Novo and PMA
Device trials
3
As lead sponsor, any status
Adverse event reports
0
Received Nov 1, 2025 to Nov 20, 2026
Recall records
0
One per recalled product
This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.
Financing
Public company. Figures from its SEC financial statements, plus private placements it reported on Form D.
Listed
OPK
Nasdaq · OPKO HEALTH, INC.
Public float
$540M
Value of shares held by non-insiders on Dec 31, 2025
Revenue
$607M
Fiscal year ending Dec 31, 2025
Net income
-$226M
Fiscal year ending Dec 31, 2025
R&D spending
$124M
Fiscal year ending Dec 31, 2025
Cash
$384M
As of Sep 30, 2026
Long-term debt
$477M
As of Sep 30, 2026
Shares outstanding
742.5M
As of Oct 20, 2026
Capital raised as a public company
Cash received from selling stock and borrowing, from each year's cash-flow statement in the annual report. Fiscal years, by the year each one ended.
| Year | IPO | Stock sold | Long-term debt | Convertible debt |
|---|---|---|---|---|
| 2024 | – | – | – | $230M |
Private placements (Form D)
One row per Form D offering, newest first. The amount raised is the latest amended figure. An offering can run for months and close in several tranches. Matched by company name, so check the filing.
| First sale | Type | Raised | Round size | Investors | Exemption and agent | Filing |
|---|---|---|---|---|---|---|
| Jan 30, 2013 | Convertible note | $175M | $175M | 105 | Rule 506Agent: Jefferies & Company, Inc., Ladenburg Thalmann & Co. | Form D ↗Feb 15, 2013 |
1 more funding rounds with a free account
Company details
From the company's latest Form D.
- Legal name
- Opko Health, Inc.
- Headquarters
- Miami, Florida
- Incorporated
- Delaware over five years before filing
- Entity type
- Corporation
- Revenue range
- $25,000,001 - $100,000,000
- Industry filed under
- Pharmaceuticals
- SEC filer
- CIK 944809 ↗
Executives, directors and promoters
As listed on the latest Form D.
11 more people on the filing with a free account
Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys. Not every round is filed: companies raising under other exemptions, or from foreign investors only, may not file Form D. Nothing here is investment advice.
Investors
5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors from funding announcements and the firms' own portfolio pages.
The investor database is free with an account
Sign up free with your name, company and ZIP code to see the 5%+ shareholders and government grant funders behind device companies.
Latest FDA decisions
- 4Kscore TestPMA
P190022 · Decided Dec 7, 2021 · 823 days after receipt
Device type: Multi-analyte test system with algorithmic analysis for detection of prostate cancer (QRF) · Laboratory Medicine & Pathology
Device trials
Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.
- Efficacy and Safety of a Intra-articular Injection, ENKO1, in Patients With Symptomatic Knee Osteoarthritis.Pivotal-lookingCompleted
NCT03762408 · 175 participants · Start Dec 15, 2017 · Primary completion May 29, 2020
Device: ENKO 1; Durolane · For: Osteoarthritis, Knee
Sites: Esplugues de Llobregat, Spain; Terrassa, Spain; Chiclana de la Frontera, Spain · 18 sites in all
2 more trials with a free account
Reports received
0
Received Nov 1, 2025 to Nov 20, 2026
Malfunction reports
0
Injury reports
0
Death reports
0
Adverse event reports received per month
Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.
No reports to chart for this view.
Device types named most often
Last 12 months, by FDA product code. A company that sells more gets more reports.
No device types to rank.
Brand names named most often
Last 12 months, as written on the reports. One product can appear under several spellings.
No brand names to rank.
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recalls under this name in FDA's data.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.